Literature DB >> 17349868

Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder.

Joseph A Gogos1.   

Abstract

Schizophrenia is a devastating psychiatric disorder that affects approximately one percent of the population worldwide. We argue that the efforts to decipher the genetic causes of schizophrenia have reached another turning point and describe evidence supporting some of the major recent genetic findings in the field. In addition, we identify some general areas of caution in the interpretation of these findings and addresses the promise this recently acquired knowledge holds for the generation of reliable animal models, characterization of genetic interactions, dissection of the disease pathophysiology and development of novel, mechanism-based treatments for the patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17349868     DOI: 10.1016/S0074-7742(06)78013-8

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  4 in total

1.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

Review 2.  Comprehensive neurocognitive endophenotyping strategies for mouse models of genetic disorders.

Authors:  Michael R Hunsaker
Journal:  Prog Neurobiol       Date:  2012-01-13       Impact factor: 11.685

Review 3.  MicroRNA dysregulation in psychiatric disease.

Authors:  Brooke H Miller; Claes Wahlestedt
Journal:  Brain Res       Date:  2010-03-18       Impact factor: 3.252

4.  Accept or refuse? A pilot study of patients' perspective on participating as imaginary research subjects in schizophrenia.

Authors:  Jin Hun Kim; Daeho Kim; Sung-Hyouk Park; Junghyun Nam
Journal:  Psychiatry Investig       Date:  2009-06-30       Impact factor: 2.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.